Search results
California Attorney General Bonta Urges Supreme Court to Uphold States’ Authority to Regulate...
Sierra Sun Times· 6 days agoOAKLAND, CA – California Attorney General Rob Bonta on Wednesday joined a bipartisan coalition of 32...
Gateway - Quartz
Quartz· 4 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 5 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
States struggle to help patients navigate insurance hurdle known as ‘step therapy’
Missouri Independent via Yahoo News· 5 days agoCassidy Yermal, 32, began experiencing debilitating migraines when she was 17 years old. As a...
Biden plan to save Medicare patients money on drugs risks empty shelves, pharmacists say
New Hampshire Union Leader· 7 days agoMonths into a new Biden administration policy intended to lower drug costs for Medicare patients,...
Letter: We need alternatives to opioids
Bangor Daily News· 2 days agoAs a retired millworker, I have witnessed the devastating impact of the opioid crisis on mill towns throughout Maine and communities around the entire...
Gateway - Quartz
Quartz· 5 days agoNovo Nordisk, the maker of the mega-popular diabetes and weight loss medications Ozempic and Wegovy, is set to report its first quarter earnings on May 2. The Danish pharma giant is one-half ...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 5 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...
